Prot# NU 02H8 (PCYC-0213): A Phase I/II Trial of Redox Regulation in Patients with Relapsed or Refractory CD20 Positive Non-Hodgkin's Lymphoma (NHL) Combining 90-Yttrium-Zevalin® and the Redox-Modulating Agent, Motexafin Gadolinium (MGd) (Prot# 106-P115)
- Gordon, Leo I (Co-PD/PI)
- Kuzel, Timothy Michael (Co-PD/PI)
- Singhal, Seema (Co-PD/PI)
- Spies, Stewart M (Co-PD/PI)
- Winter, Jane Norma (Co-PD/PI)
Project: Research project